Open Biosystems Signs Deals for RNAi Technology with Cancer Research Institutes | GenomeWeb

NEW YORK, Dec. 19 (GenomeWeb News) - Open Biosystems said today that it has signed on Duke University, the National Institutes of Health's National Cancer Institute, Lee Moffitt Cancer Center, and Fox Chase Cancer Center as customers for its short hairpin RNA libraries for the identification of cancer treatment options.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.